Table 4 Comparative summary of the published studies
Authors | Number of patients/centres included | Epoetin isoform | Variables explored (inputs) | Predictions (outputs) |
|---|---|---|---|---|
Gabutti et al (present study) | 432/29 | Beta | Sex; age; weight, presence or absence of a diabetes mellitus and/or a cardiomyopathy with EF<50%; haemoglobin; creatinine; BUN; pH; ionized calcium; albumin; CRP; ferritin; PTH; epoetin and iron dose; epoetin administration route sc vs. iv; Kt/V | Epoetin dose and follow-up haemoglobin |
Bellazzi [24] | 10/1 | n.s. | Sex; age; haemoglobin; calcium; PTH; epoetin dose and others non specified | Follow-up haemoglobin |
Martin Guerriero et al [20] | 110/1 | Alpha and beta | Age; weight; haemoglobin; ferritin; epoetin dose; isoform and number of administrations weekly; iron dose | Epoetin dose |
Gaweda et al [25] | 209/1 | n.s. | Haematocrit; albumin; ferritin; iron saturation; PTH; epoetin and iron dose; Kt/V | Follow-up haematocrit |
Jacobs et al [26] | 166/n.s. | n.s. | Haematocrit; albumin; ferritin; iron saturation; PTH; epoetin and iron dose; Kt/V | Follow-up haematocrit |